Loss of p53 exacerbates multiple myeloma phenotype by facilitating the reprogramming of hematopoietic stem/progenitor cells to malignant plasma cells by MafB.
about
Could Vitamin D Analogues Be Used to Target Leukemia Stem Cells?Is lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?Reprogramming of nonfermentative metabolism by stress-responsive transcription factors in the yeast Saccharomyces cerevisiae.p53 abnormalities and potential therapeutic targeting in multiple myeloma.p53: the barrier to cancer stem cell formation.MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells.Genetic background affects susceptibility to tumoral stem cell reprogramming.Somatic inactivation of Tp53 in hematopoietic stem cells or thymocytes predisposes mice to thymic lymphomas with clonal translocations.Function of oncogenes in cancer development: a changing paradigm.The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming.Polo-like kinase 1 inhibitors, mitotic stress and the tumor suppressor p53.Involvement of MAFB and MAFF in Retinoid-Mediated Suppression of Hepatocellular Carcinoma Invasion.Lmo2 expression defines tumor cell identity during T-cell leukemogenesis
P2860
Q26747513-B4C2F55B-6721-497E-8A4F-0116C895A201Q26779702-DF314DC0-EEA3-44B1-BB01-296CD5813225Q33363124-0DFCB585-C529-4BAA-B93E-BB5D403E494DQ33852683-9F5FC76A-1E83-4AF5-BACC-3A79C74BDF83Q34406072-C7A1F809-3F6A-449A-89BA-DFE073352F08Q35657534-D0296E9A-7697-4964-A312-66EBE23E6321Q37344811-1F9D02AF-31BA-4B9F-941D-F5917F25571CQ37452977-423ED466-4D2F-4975-8E6F-995342C4A289Q38103175-E91512E9-EADA-425B-B2F6-844AE52C14E4Q39216822-7001C1A8-AAB7-4D0B-960C-9A4496FBC98AQ41866750-DDE4511A-9B6D-41EE-AB39-B3BAF366ADB3Q54964965-C56C3198-9511-43AF-BBED-38DA5F84B92DQ58051449-D8F03359-4C57-468B-9D70-E93013FD484F
P2860
Loss of p53 exacerbates multiple myeloma phenotype by facilitating the reprogramming of hematopoietic stem/progenitor cells to malignant plasma cells by MafB.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Loss of p53 exacerbates multip ...... alignant plasma cells by MafB.
@ast
Loss of p53 exacerbates multip ...... alignant plasma cells by MafB.
@en
type
label
Loss of p53 exacerbates multip ...... alignant plasma cells by MafB.
@ast
Loss of p53 exacerbates multip ...... alignant plasma cells by MafB.
@en
prefLabel
Loss of p53 exacerbates multip ...... alignant plasma cells by MafB.
@ast
Loss of p53 exacerbates multip ...... alignant plasma cells by MafB.
@en
P2093
P2860
P356
P1433
P1476
Loss of p53 exacerbates multip ...... alignant plasma cells by MafB.
@en
P2093
Carolina Vicente-Dueñas
Francisco Javier García Criado
Inés González-Herrero
Isidro Sánchez-García
María Begoña García Cenador
P2860
P304
P356
10.4161/CC.22186
P577
2012-09-14T00:00:00Z